Father-son dispute comes to settlement at Dong-A Pharm

Published: 2007-03-29 06:56:00

Updated: 2007-03-29 06:56:00

Dong-A Pharmaceutical held a special board of directors meeting on March 26 to discuss the selection of new directors, after Pharmaceutical Chairman Kang Shin-ho and his second son Moon-seok agreed to settle disputes over management control of the nation's largest drug maker on March 22.

Senio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK